Taken together, it is suggested that genetic mutations, in particular in TP53, NF1, CDKN2A, and ERBB3 genes may contribute to the pathogenesis of sarcomatoid carcinoma. The gene discussed is TP53; the disease is sarcomatoid carcinoma.